No abstract available
Keywords:
erythema multiforme; infliximab; interstitial lung diseases; sarcoidosis.
MeSH terms
-
Aged
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects*
-
Erythema Multiforme / chemically induced*
-
Erythema Multiforme / pathology
-
Female
-
Humans
-
Infliximab / administration & dosage
-
Infliximab / adverse effects*
-
Sarcoidosis / drug therapy*
-
Sarcoidosis / pathology
Substances
-
Antibodies, Monoclonal
-
Infliximab